Core Scientific股东Two Seas Capital LP上个月表示,将投票反对该交易,并敦促其他股东也采取同样的行动。根据9月29日的一份声明,该投资公司反对这些条款,“包括估值不足、结构不完善和流程存在缺陷”。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.